Otolaryngology is experiencing significant developments from both scientific research and patient-driven recognition of conditions. Two key innovations are gene therapy for hearing loss and the identification and treatment of retrograde cricopharyngeal dysfunction, which illustrate different origins of medical progress.
I don’t know about you, but I love a good motivational sports story. In fact, I am drawn to stories of perseverance and the pursuit of excellence in any field. […]
Post-implantation music training has significant benefits in enhancing music perception in CI users, specifically in music instrument recognition, melodic contour identification, and emotion discernment; younger age, longer duration of music training, and bilateral CI use are positive predictors of success.
Cognitive behavioral therapy is an effective treatment option for individuals with bothersome tinnitus, particularly for those with high levels of tinnitus distress and anxiety.
Despite limited randomized trials specific to AERD, the consistent improvements in sinonasal outcomes across studies strongly support dupilumab as an effective treatment for AERD patients post-FESS.
TRIO’s president, Dr. Micco, shares how Triological Society meetings offer valuable opportunities for physicians to learn, connect, and rejuvenate while advancing the field of otolaryngology.
Lower lip malposition can arise after anterior mandibular resection due to lost soft tissue attachments. The authors describe using cranial suspension with fascia lata slings to enhance lip position, which alleviates drooling, improves oral intake, and restores facial aesthetics.
In this study, the authors propose a critical view of safety to promote standard visual identification and preservation of the recurrent laryngeal nerve during transoral endoscopic thyroidectomy by vestibular approach.
How does the relative availability of essential equipment for otolaryngology–head and neck surgery (OHNS) care differ across World Bank income groups?
Do disease-specific quality-of-life (QoL) outcomes following bone-anchored hearing implant (BAHI) use differ between patients with conductive/mixed hearing loss (CHL) and those with unilateral sensorineural hearing loss (U-SNHL)?